By performing a pancancer analysis of NLRP3 inflammasome-related genes across 24 human cancers, Ju M. and colleagues found that 15 cancers had significant differences in NLRP3 expression between normal and tumor samples [150]. The gene discussed is NLRP3; the disease is cancer.